2327 — Meilleure Health International Industry Income Statement
0.000.00%
Last trade - 00:00- HK$1.04bn
- HK$1.41bn
- HK$36.52m
Annual income statement for Meilleure Health International Industry, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 253 | 120 | 129 | 50.7 | 36.5 |
| Cost of Revenue | |||||
| Gross Profit | 101 | 66.8 | 78.1 | 28.9 | 22.6 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 148 | 68.3 | 60.6 | -8.04 | -7.42 |
| Operating Profit | 105 | 51.6 | 68.7 | 58.7 | 43.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 85.7 | 25.4 | 53 | 45.4 | 30.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 60.5 | 17.8 | 38.5 | 32 | 38 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 60.3 | 17.8 | 40.8 | 32.5 | 38 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 60.3 | 17.8 | 40.8 | 32.5 | 38 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.012 | 0.003 | 0.011 | 0.011 | 0.008 |
| Dividends per Share |